PL414926A1 - Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine - Google Patents
Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicineInfo
- Publication number
- PL414926A1 PL414926A1 PL414926A PL41492615A PL414926A1 PL 414926 A1 PL414926 A1 PL 414926A1 PL 414926 A PL414926 A PL 414926A PL 41492615 A PL41492615 A PL 41492615A PL 414926 A1 PL414926 A1 PL 414926A1
- Authority
- PL
- Poland
- Prior art keywords
- phenyl
- amino
- substituted
- oxopyrazolino
- medicine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
- -1 N-substituted-3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide compound Chemical class 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia jest związek o wzorze ogólnym I oraz nowe zastosowanie medyczne N-podstawionego-3-amino-4-fenylo-5-okso-pirazolinokarboksamidu związku o wzorze I, w którym R oznacza cykloheksyl, 1-naftyl, n-butyl. Związek o wzorze I stosuje się do wytwarzania leku do profilaktyki i leczenia gruźlicy.The subject of the application is a compound of the general formula I and a new medical use of the N-substituted-3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide compound of the formula I in which R is cyclohexyl, 1-naphthyl, n-butyl. The compound of formula I is used in the manufacture of a medicament for the prevention and treatment of tuberculosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414926A PL230472B1 (en) | 2015-11-24 | 2015-11-24 | Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414926A PL230472B1 (en) | 2015-11-24 | 2015-11-24 | Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL414926A1 true PL414926A1 (en) | 2017-06-05 |
| PL230472B1 PL230472B1 (en) | 2018-10-31 |
Family
ID=58793727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL414926A PL230472B1 (en) | 2015-11-24 | 2015-11-24 | Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL230472B1 (en) |
-
2015
- 2015-11-24 PL PL414926A patent/PL230472B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL230472B1 (en) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220008A1 (en) | Parp1 inhibitors | |
| SA519410865B1 (en) | Coumarin-like Cyclic Compound as MEK Inhibitor and Use Thereof | |
| UA118149C2 (en) | Jak inhibitor | |
| ZA201701299B (en) | Glycosidase inhibitors | |
| NZ736665A (en) | Heterocyclic amides as kinase inhibitors | |
| PH12016502081A1 (en) | Compounds for treating spinal muscular atrophy | |
| NZ732511A (en) | Small molecule inhibitors of egfr and pi3k | |
| MX2016013529A (en) | Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof. | |
| MD20170016A2 (en) | Aminopyrimidinyl compounds as JAK inhibitors | |
| NZ720478A (en) | Autotaxin inhibitor compounds | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| GEP201706725B (en) | Compounds and compositions as inhibitors of mek | |
| CY1122077T1 (en) | NEW CYCLED PHENOXYACETAMIDIES | |
| ZA201607489B (en) | Combination comprising a glucocorticoid and edo-s101 | |
| EA201691600A1 (en) | DIHYDROPYRIDINOUS INHIBITORS MGAT2 FOR USE IN THE TREATMENT OF METABOLIC DISORDERS | |
| TW201613578A (en) | Pharmaceutical combinations | |
| MA39765A (en) | Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| GEAP201814255A (en) | P-substituted asymmetric ureas and medical uses thereof | |
| CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| EA201700254A1 (en) | COMBINATION | |
| EA201692164A1 (en) | MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| PL413921A1 (en) | Pharmaceutical set and application of erythropoietin and of the Bruton kinase inhibitor | |
| PL414785A1 (en) | 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance |